Active immunization with < em > Pseudomonas aeruginosa < /em > vaccine protects mice from secondary < em > Pseudomonas aeruginosa < /em > challenge post-influenza virus infection

CONCLUSIONS: To develop an effective P. aeruginosa vaccine might be a promising strategy to decrease the threat of secondary P. aeruginosa infection in influenza patients.PMID:36794141 | PMC:PMC9922597 | DOI:10.21037/jtd-22-1012

Source: Journal of Thoracic Disease - February 16, 2023 Category: Respiratory Medicine Authors: Xiaofeng Wu Feilong Jie Pingchao Li Chao Zhuo Weiqi Pan Nanshan Zhong Chufang Li Ling Chen Source Type: research